Medicine's 'Basic' Mistake: How the Molecular Revolution Displaced an Entire Category of Inquiry.

The integration of molecular biology in medicine represents a remarkable achievement of modern science. Nonetheless, the success of molecular methods reshaped medicine's epistemology over time such that biological explanation came to mean explanation exclusively at the cellular or molecular level. This review argues that medicine committed a philosophical error-molecular investigation came to determine epistemic status, displacing person-level clinical research as an entire domain of rigorous inquiry. Person-level clinical research encompasses clinical observation, psychosocial and behavioral medicine, patient-reported outcomes, and the biology of biography. Each tradition satisfies established criteria used to define foundational science. For example, KRAS mutation testing shares its epistemic structure with biographical constructs such as chronic neuroendocrine dysregulation and allostatic load. Both traditions identify specific activated pathways, predict therapeutic response, stratify patients into biologically distinct populations, and operate upstream of pharmacologic interactions. The biological significance of a pathway depends on the person-level context in which it is activated. Two patients sharing the same mutation but carrying profoundly different neuroimmune histories, inflammatory set-points, and stress exposure are not the same biological system. Precision medicine, as currently practiced, is often precise at the wrong level of analysis. Evidence supporting biography as mechanistically foundational has not been refuted; it was marginalized by self-reinforcing institutional forces. Federal funding concentrated in molecular science created financial dependencies that transformed an epistemological preference into a structural imperative. Tenure structures systematically protected molecular faculty whereas clinical scientists were moved to contingent appointments. Successive generations of trainees oriented rationally toward the molecular model. The displacement of person-level clinical research was not a scientific decision. It was a historical accident compounded by the financial and administrative architecture of modern academic medicine. Restoring this domain to foundational status is not a humanistic plea; it is a scientific corrective-and its costs, if deferred, are borne by patients.